Cargando…
Utility of Survival Motor Neuron ELISA for Spinal Muscular Atrophy Clinical and Preclinical Analyses
OBJECTIVES: Genetic defects leading to the reduction of the survival motor neuron protein (SMN) are a causal factor for Spinal Muscular Atrophy (SMA). While there are a number of therapies under evaluation as potential treatments for SMA, there is a critical lack of a biomarker method for assessing...
Autores principales: | Kobayashi, Dione T., Olson, Rory J., Sly, Laurel, Swanson, Chad J., Chung, Brett, Naryshkin, Nikolai, Narasimhan, Jana, Bhattacharyya, Anuradha, Mullenix, Michael, Chen, Karen S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164180/ https://www.ncbi.nlm.nih.gov/pubmed/21904622 http://dx.doi.org/10.1371/journal.pone.0024269 |
Ejemplares similares
-
Limited Assessment of Respiratory Muscle Response to Nusinersen Treatment in Infants with Spinal Muscular Atrophy
por: Chacko, Archana, et al.
Publicado: (2020) -
Evaluation of Peripheral Blood Mononuclear Cell Processing and Analysis for Survival Motor Neuron Protein
por: Kobayashi, Dione T., et al.
Publicado: (2012) -
SMA-MAP: A Plasma Protein Panel for Spinal Muscular Atrophy
por: Kobayashi, Dione T., et al.
Publicado: (2013) -
Pharmacokinetics, pharmacodynamics, and efficacy of a small-molecule SMN2 splicing modifier in mouse models of spinal muscular atrophy
por: Zhao, Xin, et al.
Publicado: (2016) -
Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)